University of Massachusetts Medical School - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Massachusetts Medical School - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Massachusetts Medical School - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Massachusetts Medical School - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
22 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Massachusetts Medical School (UMMS), a subsidiary of University of Massachusetts is a research and healthcare institute that offers educational services. The institute offers both under graduate and graduate programmes in various medical areas. It provides mental health and pediatric services. UMMS institute carries out both clinical and basic research. in the areas of HIV, cancer, diabetes, infectious disease and molecular basis of disease. The institute provides health and science education through its three graduate schools, namely, the School of Medicine, Graduate School of Nursing and Graduate School of Biomedical Sciences.

University of Massachusetts Medical School - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH142301D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Massachusetts Medical School, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Massachusetts Medical School, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Massachusetts Medical School, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Massachusetts Medical School, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
University of Massachusetts Medical School, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
University of Massachusetts Medical School, Pharmaceuticals &Healthcare, Deal Details109
  Partnerships101
    Quad Technologies Partners with University of Massachusetts Medical School101
    Lysogene Enters into Agreement with University of Massachusetts Medical School and Auburn University111
    BioServe Biotechnologies Enters Into Strategic Alliance With The University of Massachusetts Medical School121
    RXi Pharma Enters Into Co-Development Agreement With The UMMS131
  Licensing Agreements141
    Amarantus Bioscience Enters Into Licensing Agreement With University of Massachusetts Medical School141
    University of Massachusetts Medical School Enters Into Licensing Agreement With Agalimmune For Alphaject152
    The University of Massachusetts Medical Enters Into Licensing Agreement With Merck172
University of Massachusetts Medical School - Key Competitors191
Key Employees201
Locations And Subsidiaries211
  Head Office211
Appendix221
  Methodology221
  About GlobalData221
  Contact Us221
  Disclaimer221

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Massachusetts Medical School - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Massachusetts-Medical-School-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7723>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Massachusetts Medical School - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Massachusetts-Medical-School-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7723>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research